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Abstract-We studied the effects of various b-adrenoceptor (BAR) antagonists and local anesthetics 
(LAS), i.e. substances possessing one basic and one lipophilic domain each, on activation of regulatory 
heterotrimeric guanine nucleotide-binding proteins (G-proteins). In membranes of differentiated HL- 
60 cells, propranolol activated high-affinity GTP hydrolysis with a half-maximal effect at 0.19 mM and 
a maximum at 1 mM. There was a close correlation between the log Q values (logarithm of the octanol: 
water partition coefficient) of PAR antagonists and the logarithm of their effectiveness at activating 
GTPase (EC 3.6.1.-) in HL-60 membranes. The lipophilic LA, tetracaine, was also an effective activator 
of GTPase in HL-60 membranes, whereas more hydrophilic LAS were less stimulatory (bupivacaine 
and lidocaine) or even inhibitory (procaine). Propranolol and tetracaine also stimulated binding of 
guanosine 5’-0-[3-thioltriphosphate (GTP[@]) to HL-60 membranes, but their stimulatory effects on 
GTP[@] binding were smaller than on GTP hydrolysis. The stimulatory effects of propranolol and 
tetracaine on GTPase and GTP[@] binding were inhibited by pertussis toxin. Propranolol and tetracaine 
effectively activated GTP hydrolysis of a reconstituted mixture of bovine brain Gi/G,-proteins, but the 
concentrations of substances needed for GTPase activation were higher than in HL-60 membranes. 
Procaine showed stimulatory effects on the GTPase of G,/G,-proteins. Our data show that BAR 
antagonists and LAS activate pertussis toxin-sensitive G-proteins, presumably through interaction with 
the C-terminus of their cu-subunits. Apparently, the lipophilic domain of BAR antagonists and LAS is 
more important for G-protein activation than the basic domain. We discuss the possibility that activation 
of nucleoside diphosphate kinase by PAR antagonists and LAS contributes to their stimulatory effects 
on GTP hydrolysis in HL-60 membranes. 
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Numerous intercellular signal molecules exert their 
effects through receptors which interact with G- 
proteins5 [ 1,2]. G-protein-coupled receptors possess 
seven putative transmembrane domains three 
extracellular and three cytoplasmic loops. There is 
evidence to support the assumption that the second 
and third cytoplasmic loop are important for G- 
protein activation [2]. Recent studies have shown 
that cationic-amphiphilic substances such as com- 
pound 48180 and the tetradecapeptide, mastoparan, 
activate PTX-sensitive G-proteins, i.e., Gi- and G,- 
proteins, directly, presumably by acting as substitutes 
for the third cytoplasmic loop of receptors (3-71. 
Studies with mastoparan and mastoparan derivatives 
have shown that lipophilicity of the peptides is 
important for G-protein activation [4]. 
@AR antagonists and LAS are cationic-amphiphilic 
substances, i.e. they possess one basic and one 
lipophilic domain each and show substantial 
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differences in lipophilicity [8,9]. We therefore used 
BAR antagonists and LAS as model substances to 
learn more about the relative importance of lipophilic 
and basic domains of cationic-amphiphilic substances 
for G-protein activation. We show here that /3AR 
antagonists and LAS directly activate PTX-sensitive 
G-proteins and that lipophilicity increases their 
effectiveness in this regard. 
MATERIALS AND METHODS 
Materials. PAR antagonists, (-)-isoproterenol, 
LAS, azolectine and mastoparan were obtained from 
the Sigma Chemical Co. (Deisenhofen, Germany). 
With the exception of (-)- and (+)-propranolol and 
(-)-timolol, racemates of PAR antagonists were 
employed. Unless stated otherwise, experiments 
were performed with racemic propranolol. Stock 
solutions of metroprolol tartrate, timolol maleate, 
hydrochlorides of the other /3AR antagonists and 
hydrochlorides of LAS (30 mM each) were prepared 
in distilled water and were stored at -20”. [“%I- 
guanosine 5’-0-[3_thio]triphosphate [35S]GTP[yS]) 
(1000-1500 Ci/mmol) was obtained from DuPont/ 
New England Nuclear (Bad Homburg, Germany). 
Sources of other materials have, been described 
elsewhere [10-131. 
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Cell culiure and membrane preparation. HL-60 
ceils were grown in suspension culture at 37” and 
were terminated by rapid filtration through cellulose 
were differentiated towards neutrophil-like cells with 
nitrate BA 85 filters (Schleicher & Schuell, Dassel, 
dibutyryi CAMP (0.2 mM) for 48 hr [13]. Membranes 
Germany) followed by two washes with 5 mL of 
were prepared as described [lo]. PTX (100 ng/mL) 
buffer (0”) consisting of 5 mM MgClz and 50mM 
or its carrier (control) were added to cell cultures 
triethanolamine/HCl, pH 7.4. Filter-bound radio- 
24 hr before membrane preparation. Under these 
activity was determined in a liquid scintillation 
conditions, >95% of Gi-protein a-subunits were 
counter. Non-specific binding was determined in the 
ADP-ribosylated (data not shown). 
presence of 10 PM GTP[@] and was less than 1% 
of total binding. 
Pur~cat~o~ and reco~st~t~tio~ of G-proteins. A 
mixture of heterot~me~c Gi/G~-proteins was 
purified from bovine brain membranes [12]. Briefly, 
cholate extracts of membranes were subjected to 
chromatography on a DEAE-Sepharose Fast Flow 
column (Pharmacia, Freiburg, Germany), followed 
by an AcA 34 gel filtration column (Serva, 
Heidelberg, Germany) and a Heptylamine- 
Sepharose column. Fractions were analysed for 
GTP[yS] binding and immunoreactivity using specific 
antibodies [ll, 121. Purity of pooled heterot~meric 
G-proteins was estimated by SDS-PAGE and silver- 
staining and was >90%. The purified mixture 
contained predominantly Gol, substantial amounts 
of Goz, Gil and Gir and traces of Gis. 
~~cellaneo~. Protein was determined according 
to Lowry et al. [15]. [T-~‘P]GTP was prepared as 
described [16]. Data shown in Figs 1,3,4 and 5 and 
Table 1 are the means of assay quadruplicates of a 
representative experiment. Similar results were 
obtained in at least three independent experiments. 
The SD values were generally ~5% of the means. 
The statistical significance of the stimulatory effects 
of pindolol, nadolol and atenolol on GTPase in HL- 
60 membranes (Fig. 1) was assessed using the 
Wilcoxon test. The regression line shown in Fig. 2 
was calculated using the program, Sigmaplot 4.0 
(Jandel, Erkrath, Germany). 
Reconstitution of purified G-proteins into 
phospholipid vesicles was performed essentially as 
described by Tomitaetal. [6] with slightmodifications. 
In brief, a purified mixture of bovine brain Gi/GO 
proteins ~25-3Opmoles) was mixed with azolectine 
(O-l%, w/v), sodium cholate (l%, w/v) in a buffer 
consisting of 100 mM NaCl, 2 mM MgCl,, 1 mM 
EDTA and 20 mM HEPES/NaOH, pH 8.0,4”, and 
loaded onto a 10mL AcA 34 gel filtration column 
(25 cm x 8.5 mm) equilibrated with the above buffer. 
Liposomes eluted in the void volume. Association 
of G-proteins with liposomes was confirmed by 
GTP[yS] binding. Pooled fractions were then used 
for measurement of GTP hydrolysis. 
RESULTS 
Me~ureme~toft~eactivi~ofGTPase(EC3.6.1.-). 
GTP hydrolysis was determined as described (131. 
For determination of GTP hydrolysis in membranes 
from dibutyryl CAMP-differentiated HL-60 cells, 
reaction mixtures (1OU pL) contained 3.e7.0 pg 
of membrane protein/tube, 0.5 @f [y - 32P]GTP 
(0.1 &i/tube), 0.5 mM MgC12, 0.1 mM EGTA, 
0.1 mM ATP, 1 mM adenosine 5’ - [P,r - imidol- 
triphosphate, 5 mM creatine phosphate, 40,ug of 
creatine kinase, 1 mM dithiothreitol and 0.2% 
(w/v) bovine serum albumin in SOmM 
triethanolamine/HCl, pH 7.4. Reactions were con- 
ducted for 15 min at 25”. For determination of the 
GTPase activity of reconstituted G-proteins, reaction 
mixtures (100 pL) contained 0.4-0.6 pmoles of 
Gi/G,-proteins, 50 nM [Y-~~P]GTP (0.1 pCi/tube), 
1mM MgClz and OSmM EDTA. The other 
conditions were as described above. 
The effects of @AR antagonists on high-affini~ 
GTP hydrolysis, i.e. the enzymatic activity of G- 
protein cu-subunits, in HL-60 membranes were 
studied. HL-60 cells contain mostly the G-protein, 
Gi2, and, to a lesser extent, Gis and G,, and are a 
widely used model system for the analysis of G- 
protein-mediated signal transduction processes [171. 
Propranolol activated GTPase with an ECUS of 
0.19mM and a plateau at l-3 mM (Fig. 1). At 
maximally effective concentrations, propranolol 
increased GTP hydrolysis by 85-90%. Stimulation 
of GTP hydrolysis by propranolol was due to an 
increase in V,,, without a change in Km (data not 
shown), indicating that the substance increased the 
catalytic rate of GTP turnover. In membranes 
from PTX-treated cells, the stimulatory effect of 
propranolol on GTPase was almost prevented (Table 
1). (+)-Propranolol and (-)-propranolol activated 
GTPase with a very similar potency and effectiveness 
as racemic propranolol (see Fig. 1). 
Assay for GTP[yS] binding in HL-60 membranes. 
(3sS]GTP[@] binding in HL-60 membranes was 
assessed according to Wieland et al. [14] with 
modifications, In brief, reaction mixtures (1001_1L) 
contained membranes from dibutyryl CAMP-dif- 
ferentiated HL-60 cells (3.0-5.0 pg of protein/tube), 
0.4 nM [3sS]GTP[$i], 5 mM MgC12, 1 mM EDTA, 
1 mM dithiothreitol and 0.2% (w/v) bovine serum 
albumin in 50 mM t~ethanolamine/H~l, pH 7.4. 
Reactions were conducted for 60 min at 0”. Reactions 
Other BAR antagonists activated GTP hydrolysis 
in HL-60 membranes in a concentration-dependent 
manner as well, but, their stimulatory effects did not 
reach saturation until 3 mM (see Fig. 1). The order 
of effectiveness of /JAR antagonists at activating 
GTP hydrolysis was propranolol > alprenolol > 
metoprolol > timolol > pindolol > nadolol > 
atenolol (Fig. 2). There was a close correlation (r = 
0.98) between the log Q values, i.e. the logarithm 
of the octanol: water partition coefficient of @AR 
antagonists 181, and the logarithm of their effec- 
tiveness to activate GTPase (see Fig. 2). 
In marked contrast to PAR antagonists, the @AR 
agonist, (-)-isoproterenol (l-lOO@M), did not 
stimulate GTP hydrolysis in HL-60 membranes (data 
not shown). Mastoparan at a maximally effective 
concentration (10 PM) increased GTPase activity in 
HL-60 membranes by 85% (data not shown). 
The effects of some LAS on GTP hydrolysis in 
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Fig. 1. Concentration-response curves for various /JAR antagonists on high-af~nity GTP hydrolysis in 
membranes from dibutyryl CAMP-differentiated HL-60 cells. GTP hydrolysis was determined as 
described in Materials and Methods. Reaction mixtures contained @AR antagonists at the indicated 
concentrations. Panel A: racemic propranolol (a), (-)-propranolol (V), (+)-propranolol (A). Panel 
B: propranolol (O), alprenolol (0), metoprolol (II), timolol (O), pindolol (+), nadolol (o), atenolol 
(A). Basal GTP hydrolysis rate was 15.3 t 0.5 pmol/mg/min. The stimulatory effects of pindolol were 
significant (P < 0.05) at a concentration of 0.3 mM and above, and those of nadolol and atenolol were 
si~ificant (P < 0.05) at 3 mM. 
Table 1. Effect of pertussis toxin on stimulations of GTP hydrolysis and GTP[yS] binding by 
propranolol and tetracaine in membranes from dibuty~l CAMP-differentiated HL-60 cells 
Addition 
None (basal) 
Propranolol (1 mM) 
Tetracaine (1 mM) 
GTP hydrolysis 
Cont$;lOl/mg/miniTX 
15.2 % 0.4 7.0 +- 0.2 
28.0 + 0.4 7.3 2 0.3 
24.0 t 0.3 7.2 * 0.5 
GTP[1/s] binding 
Control(pmol/mg) 
PTX 
1.12 * 0.05 0.85 t 0.07 
1.52 r 0.04 0.83 r 0.06 
1.55 _’ 0.03 0.87 t 0.01 
Pretreatment of HL-60 cells with PTX or carrier (control) was as described in Materials 
and Methods. GTP hydrolysis and GTP[#] binding in HL-60 membranes were also determined 
as described in Materials and Methods. 
HL-60 membranes are shown in Fig. 3. Tetracaine, 
bupivacaine and lidocaine activated GTPase in a 
concentration-dependent manner. As was the case 
for most PAR antagonists (see Fig. l), the stimulatory 
effects of LAS did not reach saturation until 3 mM. 
The order of effectiveness of LAS at activating 
GTPase was tetracaine > bupivacaine > lidocaine. 
With respect to these LAS, high lipophilicity was 
associated with high effectiveness at activating GTP 
hydrolysis (Table 2). Among the LAS studied, 
procaine was the most hydrophilic one (see Table 
2) [9], and this LA reduced GTP hydrolysis up to 
20% below basal values in HL-60 membranes (see 
Fig. 3). Tetracaine (3 mM) and propranolol (I mM) 
were similarly effective at stimulating GTP hydrolysis 
(see Figs 1 and 3). 
We also studied the effects of some /3AR 
antagonists on the GTPase activity of a mixture of 
reconstituted G/G,-proteins. In accordance with 
the results obtained for HL-60 membranes (see Figs 
1 and 2), propranolol was much more effective than 
pindolol at activating GTP hydrolysis of reconstituted 
G- roteins (Fig. 4). Stimulation of the GTPase of 
G- Go-proteins by propranolol did not reach ,P 
saturation, even at a concentration as high as 5 mM. 
At this high concentration, propranolol increased 
GTP hydrolysis by 130%. Metoprolol and pindolol 
were similarly effective activators of the GTPase of 
Gi/G,-proteins. Mastoparan (100 ,uM) increased 
GTP hydrolysis of the reconstituted G-proteins by 
60% (data not shown). 
Tetracaine also activated the GTPase of recon- 
stituted Gi/G~-proteinsin a concentration-dependent 
manner (Fig. 5). Similar to propranolol, the 
concentrations of tetracaine required to activate 
Gi/G,-proteins were higher than those needed for 
activation of GTP hydrolysis in HL-60 membranes 
(compare Figs 1 and 4 and Figs 3 and 5). Similar to 
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Fig. 2. Correlation between the log Q values of BAR 
antagonists and their effectiveness at activating GTP 
hydrolysis in HL-60 membranes. The log Q values for /JAR 
antagonists were taken from Ref. 8. The stimulatory effects 
of BAR antagonists (1 mM each) on GTP hydrolysis in 
HL-60 membranes are the means of five independent 
experiments. The increase in GTP hydrolysis caused by 
propranolol was defined as 100%. The stimulatory effects 
of the other BAR antagonists were related to this value. 
Log Q values were plotted against the logarithm of the 
effectiveness of PAR antagonists to activate GTPase. 
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Fie. 3. Concentration-response curves for various LAS on 
high-affinity GTP hydrolysis in membranes from dibutyryl 
CAMP-differentiated HL-60 cells. GTP hvdrolvsis in HL- 
60 membranes was determined as described in Materials 
and Methods. Reaction mixtures contained tetracaine (A), 
bupivacaine (W), lidocaine (0) and procaine (V) at the 
indicated concentrations. Basal GTP hydrolysis rate was 
16.2 ? 0.6 pmol/mg/min. 
the results obtained with HL-60 membranes, an 
increase in lipophilicity of LAS (lidocaine < 
bupivacaine < tetracaine) resulted in an increase in 
effectiveness of substances at activating the GTPase 
of reconstituted Gi/G,-proteins (see Fig. 5 and Table 
2). In contrast to HL-60 membranes, procaine 
showed stimulatory effects on GTP hydrolysis by 
Gi/G,-proteins, and this LA was even slightly more 
effective than lidocaine (see Figs 3 and 5 and Table 
2). 
In addition to stimulation of high-affinity GTP 
hydrolysis, stimulation of GTP[#] binding is a 
parameter reflecting G-protein activation [14]. In 
HL-60 membranes, both propranolol and tetracaine 
stimulated GTP[yS] binding in a PTX-sensitive 
manner (see Table 1). However, compared to GTP 
hydrolysis, the stimulatory effects of propranolol 
and tetracaine on GTP[I/S] binding in HL-60 
membranes were smaller (84% vs 36% stimulation 
in the case of propranolol and 58% vs 38% 
stimulation in the case of tetracaine) (see Table 1). 
DISCUSSION 
In order to learn more about the properties of 
cationic-amphiphilic substances needed for direct G- 
protein activation we employed PAR antagonists 
and LAS as model substances. We found that BAR 
antagonists and LAS increased GTP hydrolysis and 
GTP[yS] binding in HL-60 membranes in a PTX- 
sensitive manner, indicating that they activate Gi- 
proteins (see Figs 1 and 3 and Table 1). In accordance 
with this, the substances also activated the GTPase 
of reconstituted Gi/G,-proteins (see Figs 4 and 5). 
Unlike PAR antagonists, the @AR agonist, (-)- 
isoproterenol, did not stimulate high-affinity GTP 
hydrolysis in HL-60 membranes. In addition, the 
stimulatory effects of propranolol on GTPase and 
GTP[yS] binding in HL-60 membranes were almost 
or completely inhibited by PTX (see Table 1). 
Moreover, (+)- and (-)-propranolol were similarly 
potent and effective at activating GTPase although 
they possess different affinities to /?ARs (see Fig. 1) 
[18]. Thus, it is unlikely that activation of PARS and 
the PTX-insensitive G-protein, G, [ 11, substantially 
contributed to the stimulatory effects of PAR 
antagonists on high-affinity GTPase in HL-60 
membranes. 
As @AR antagonists and LAS may change physical 
membrane properties [l&20] the question arises 
whether they activate PTX-sensitive G-proteins by 
altering this parameter. An argument in favor of 
this assumption may be the finding that (+)- and 
(-)-propranolol were similarly potent and effective 
at activating GTP hydrolysis in HL-60 membranes 
(see Fig. 1). However, the data obtained with 
membranes from PTX-penetrated HL-60 cells do 
not support this view. PTX catalyses the ADP- 
ribosylation of a cysteine residue near the C-terminus 
of Gi-protein a-subunits [l] and, thereby, inhibits 
the stimulatory effects of mastoparan and compound 
48/80 on GTP hydrol sis of, and GTP[yS] binding 
to, reconstituted Gi Go-proteins [3,5,6]. If the r 
stimulatory effects of PAR antagonists and LAS on 
GTP hydrolysis and GTP[$S] binding in HL-60 
membranes were due to changes in physical 
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Table 2. Comparison of the log Q values of LAS and their effectiveness at activating 
GTP hydrolysis in HL-60 membranes and of reconstituted G,/G,-proteins 
LA 
Procaine 
Lidocaine 
Bupivacaine 
Tetracaine 
L,og Q value 
-0.22 
0.46 
1.45 
1.90 
Log G-protein activation 
HL-60 membranes GIGS-proteins 
_* 1.13 
1.18 1.02 
1.64 1.34 
2.00 2.00 
The log Q values for LAS were taken from Ref. 7. The stimulatory effects of LAS 
(3 mM each) on GTPase in HL-60 membranes were taken from Fig. 3. and those of 
iAs (5 mM’each) on GTP hydrolysis of reconstituted Gi/G,-proteins w&e taken from 
Fig. 5. The increase in GTP hydrolysis caused by tetracaine was defined as 100%. The 
stimulatory effects of the other LAS were related to this value. The logarithm of the 
effectiveness of LAS at activating GTPase was calculated. 
* Procaine did not stimulate but rather inhibited GTP hydrolysis in HL-60 membranes. 
6.0 5.0 4.0 3.0 2.0 
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Fig. 4. Concentration-response curves for some /3AR 
antagonists on high-affinity GTP hydrolysis of a recon- 
stituted mixture of G,/G,-proteins. G-proteins purified 
from bovine brain were reconstituted into phospholipid 
vesicles and assayed for GTP hydrolysis as described in 
Materials and Methods. Reaction mixtures contained 
propr~oloi (O), metoprolot (+) or pindolol (m) at the 
indicated concentrations. Basal GTP turnover was 
0.085 min-‘. 
membrane properties, PTX would not be expected 
to greatly affect the stimulatory effects of these 
substances. However, the toxin strongly inhibited 
the stimulatory effects of propranolol and tetracaine 
on GTPase and GTP[yS] binding (see Table I). 
These data suggest that the stimulatory effects of 
BAR antagonists and LAS are attributable to 
interaction of these substances with C-terminal 
portions of Gi-protein u+subunits. It remains to be 
clarified inasmuch as /3ycomplexes are involved in 
the interaction of PAR antagonists and LAS with G- 
proteins and of whether these substances affect the 
anchoring of G-protein a-subunits to the plasma 
membrane. 
There is a close correlation between the 
lipophilicity of /3AR antagonists and their effec- 
tiveness to activate Gi-proteins in HL-60 membranes 
(see Fig. 2). In addition propranolol, the most 
1ipophilic~AR antagonist studied, was more effective 
than less lipophilic substances of this class of drugs 
to activate the GTPase of reconstituted GJG,- 
proteins (see Fig. 4). Moreover, lipophilic LAS were 
more effective than hydrophilic ones at activating 
the GTPase in HL-60 membranes and of reconstituted 
Gi/G,-proteins (see Figs 3 and 5 and Table 2). These 
data suggest that the lipophilic domain of /3AR 
antagonists and LAS is more important than the 
basic one for effective G-protein activation. With 
respect to mastoparan and mastoparan derivatives, 
lipophilicity of peptides is also important for effective 
G-protein activation [4]. 
Procaine reduced GTP hydrolysis in HL-60 
membranes, but it slightly increased that of 
reconstituted Gi/GO-proteins (see Figs 3 and 5). In 
addition, metoprolol (3mM) was more effective 
than pindolol (3 mM) at activating GTP hydrolysis 
in HL-60 membranes, but, were similarly effective 
with respect to Gi/G,-proteins (see Figs 1 and 4). 
These data suggest that the mechanisms by which 
@AR antagonists and LAS activate Gi-proteins in 
HL-60 membranes and reconstituted Gi/G,-proteins 
are not identical. Activation of NDPK (EC 2.7.4.6) 
by mastoparan may play an important role in its 
stimulatory effects on GTP hydrolysis in HL-60 
membranes, and mastoparan is only a poor activator 
of GTP[ySf binding in this system 1211. Similarly, 
propranolol and tetracaine were more effective 
activators of GTP hydrolysis than of GTP[ yS J binding 
in HL-60 membranes (see Table 1). In addition, 
mastoparan is a considerably more potent activator 
of purified NDPK than of reconstituted Go-proteins 
1221. Intriguingly, the concentrations of propranolol 
and tetracaine required to activate GTP hydrolysis 
of reconstituted Gi~G~-proteins were also higher 
than those needed for GTPase activation in HL-60 
membranes (compare Figs 1 and 4 and Figs 3 and 
5). Thus, by analogy to mastoparan, a part of the 
stimulatory effects of /3AR antagonists and LAS on 
GTP hydrolysis in HL-60 membranes may be 
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Fig. 5. Effects of various LAS on high-af~~ty GTP hydrolysis by a reconstituted mixture of Gl/GO- 
proteins. G-proteins purified from bovine brain were reconstituted into phospholipid vesicfes and 
assayed for GTP hydrolysis as described in Materials and Methods. Pane1 A: conc~nt~tio~response 
curve for tetracaine. Panel B: comparison of the stimulatory effects of various LAS (5 mM each) on 
GTP hydrolysis. PRO, pro~ine~ LID, Iidocaine; BUP, bupivacaine; TET, tetracaine. Basal GTP 
turnover was 0.085 mm-‘. 
mediated through activation of NDPK by these 
substances. 
Our data also suggest that the structure-activity 
relationships of @AR antagonists and LAS for 
interaction with G-proteins and NDPK may be 
different, e.g. metoproIo1 may be a more effective 
activator of NDPK than pindolol (see Figs 1 and 4), 
and procaine may be a weak activator of G”proteins 
but not of NDPK {see Figs 3 and 5). If nucleoside 
diphosphate kinase is, in fact, involved in G-protein 
activation by @AR antagonists and LAS in situ, the 
PTX-sensitivity of the stimulatory effects of 
propranoiol and tetracaine on GTPase implies that 
ADP-ribosylation interferes with the channeling of 
GTP from NDPK to the G-protein (see Table 1). 
directly or indirectly through stimulation of NDPK, 
contributes to their therapeutic and/or toxic effects. 
Testing of this hypothesis will require, for example, 
assessment of the effect of PTX on the actions of 
LAS in isolated neurons and cardiac tissue and in 
intact animals. 
In conclusion, we have shown that lipophili~ #IAR 
antagonists and LAS are effective direct activators of 
PTX-sensitive G-proteins in situ and in reconstituted 
systems. Apparently, the lipophilic domain of these 
substancesis more important for G-protein activation 
than the basic one. Activation by j3AR antagonists 
and LAS of the GTPase of Gi-proteins in HL-60 
membranes may involve NDPK. 
The concentrations of propranolol required to 
activate G-proteins are substantially higher than 
those obtainable in r&o (see Figs 1 and 4) [23]. 
Thus, it is most unlikely that G-protein activation 
induced by @AR antagonists contributes to their 
therapeutic effects in the treatment of cardiac 
arrhythmias, angina and h~~ension 1231. However, 
the ~on~ntrat~ons of LAs inducing local anesthesia 
and/or cardiac and neuronal toxicity are within the 
same order of magnitude as those required for 
activation of G-proteins (see Figs 3 and 5) ]24,2S). 
Although it is genera@ assumed that LAS exert 
their therapeutic and toxic effects via inhibition of 
voltage-dependent sodium channels, additional, yet 
unknown mechanisms are likely to be involved 
19,241. Interestingiy, the anesthetic potency of LAS 
is related to their lipophili~ity, and lipophili~ LAS 
are more effective G-protein activators than 
hydrophilic ones (see Figs 3 and S and Table 2) [9]. 
Moreover, various types of ion channels are regulated 
by G-proteins [l]. From all these findings the 
int~~~g question arises inasmuch as activation of 
PI’X-sensitive G-proteins by LAS, mediated either 
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